OneMedNet Corp (ONMD)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
$4.54+7.84%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
QuarterlyIQ Insights · ONMD
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 146.5% |
| Our one-year growth estimate | diamond | 100.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 46.5 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of —
ONMD — capital allocation — Material
Dated 2026-09-29
Material Modification to the Rights of Security Holders. The information set forth in
Why it matters: Revenue rose to $292,000 in Q2, but ONMD still reports losses. Q3 results will show if sales keep growing.
Watch forQ3 revenue is above $292,000, the stated Q2 level.
Also watch forQ3 revenue is below $292,000, or the company reports no revenue.
Why it matters: Lower losses would extend the recent improvement. Higher losses would show that the path toward lower costs has stalled.
Watch forQ3 operating loss is less than $2.26 million.
Also watch forQ3 operating loss is greater than $2.26 million.
Why it matters: The 1-for-10 split was meant to help ONMD meet Nasdaq's minimum bid-price rule. A compliance notice would show whether it worked.
Watch forNasdaq confirms ONMD met the minimum bid-price rule after the September 29, 2026 split.
Also watch forNasdaq says ONMD still fails the minimum bid-price rule, or gives the company a new deadline to meet it.
Why it matters: The agreement can provide cash through share sales, but it can also add shares. The next filing can show if ONMD uses it and on what terms.
Watch forA filing reports Yorkville share sales that bring cash to ONMD, with the number of shares and proceeds disclosed.
Also watch forA filing says Yorkville sold no shares, or ONMD reports limits that block access to the agreement.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$278 on $10,000 · ±2.8% | How much price usually moves either way. |
| Bad day | $1,117 loss on $10,000 · 11.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,985 loss on $10,000 · 79.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.